480 related articles for article (PubMed ID: 24794118)
1. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
Lee CJ; Pallisgaard JL; Olesen JB; Carlson N; Lamberts M; Gislason GH; Torp-Pedersen C; Brandes A; Husted SE; Johnsen SP; Hansen ML
J Am Coll Cardiol; 2017 Jun; 69(24):2901-2909. PubMed ID: 28619189
[TBL] [Abstract][Full Text] [Related]
5. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
[TBL] [Abstract][Full Text] [Related]
6. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
7. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
[TBL] [Abstract][Full Text] [Related]
8. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.
Olesen JB; Lip GY; Lindhardsen J; Lane DA; Ahlehoff O; Hansen ML; Raunsø J; Tolstrup JS; Hansen PR; Gislason GH; Torp-Pedersen C
Thromb Haemost; 2011 Oct; 106(4):739-49. PubMed ID: 21789337
[TBL] [Abstract][Full Text] [Related]
9. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
10. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
[TBL] [Abstract][Full Text] [Related]
11. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
12. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study.
Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH
Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512
[TBL] [Abstract][Full Text] [Related]
13. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
14. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
[TBL] [Abstract][Full Text] [Related]
15. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
17. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation: a primary care cross-sectional study.
Mashal A; Katz A; Shvartzman P
Isr Med Assoc J; 2011 Nov; 13(11):666-71. PubMed ID: 22279699
[TBL] [Abstract][Full Text] [Related]
19. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
[TBL] [Abstract][Full Text] [Related]
20. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]